This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Ascendo Biotechnology, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Ling-Chiao Wu: Innovator in Immunoresponse Modulation
Introduction
Ling-Chiao Wu is a prominent inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of immunology, particularly in the modulation of immune responses. His innovative work has the potential to impact treatments for diseases associated with immune suppression.
Latest Patents
Ling-Chiao Wu holds a patent titled "Methods and antibodies for modulation of immunoresponse." This patent describes a method for reversing immune suppression or immune exhaustion. The method involves administering a composition to a subject in need of treatment, where the composition contains a CD11b modulator that specifically binds to CD11b on a cell to inhibit PD-L1 expression. The CD11b modulator can be an antibody, an antigen-binding portion thereof, or a compound as described in the patent. He has 1 patent to his name.
Career Highlights
Throughout his career, Ling-Chiao Wu has worked with notable organizations, including Ascendo Biotechnology, Inc. and Mackay Medical Foundation at the Presbyterian Church in Taiwan Mackay Memorial Hospital. His experience in these institutions has allowed him to further his research and development in immunology.
Collaborations
Ling-Chiao Wu has collaborated with esteemed colleagues, including Yen-Ta Lu and Chia-Ming Chang. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Ling-Chiao Wu is a dedicated inventor whose work in immunoresponse modulation holds promise for future medical advancements. His contributions to the field are noteworthy and reflect his commitment to improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile